Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice

被引:184
作者
Vlaming, Maria L. H. [1 ]
Lagas, Jurjen S. [1 ]
Schinkel, Alfred H. [1 ]
机构
[1] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands
关键词
BCRP/Bcrp1; Blood-brain barrier; Blood-placental barrier; Blood-testis barrier; Blood-retinal barrier; Mammary gland; Vitamin transport; Harderian gland; Porphyrins; Phytoestrogens; CANCER RESISTANCE PROTEIN; BLOOD-BRAIN-BARRIER; LIMITS FETAL DISTRIBUTION; P-GLYCOPROTEIN; MILK SECRETION; IN-VIVO; EFFLUX TRANSPORTERS; PROTOPORPHYRIN-IX; DRUG TRANSPORTERS; HARDERIAN-GLAND;
D O I
10.1016/j.addr.2008.08.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The multidrug transporter ABCG2 (BCRP/MXR/ABCP) can actively extrude a broad range of endogenous and exogenous substrates across biological membranes. ABCG2 limits oral availability and mediates hepatobiliary and renal excretion of its substrates, and thus influences the pharmacokinetics of many drugs. Recent work. relying mainly on the use of Abcg2(-/-) mice, has revealed important contributions of ABCG2 to the blood-brain, blood-testis and blood-fetal barriers. Together, these functions indicate a primary biological role of ABCG2 in protecting the organism from a range of xenobiotics. In addition, several other physiological functions of ABCG2 have been observed. including extrusion of porphyrins and/or porphyrin conjugates from hematopoietic cells, liver and harderian gland, as well as secretion of vitamin B-2 (riboflavin) and possibly other vitamins (biotin, vitamin K) into breast milk. However, the physiological significance of these processes has been difficult to establish, indicating that there is still a lot to learn about this intriguing protein. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 25
页数:12
相关论文
共 67 条
[1]   17β-estradiol and environmental estrogens significantly affect mammalian sperm function [J].
Adeoya-Osiguwa, SA ;
Markoulaki, S ;
Pocock, V ;
Milligan, SR ;
Fraser, LR .
HUMAN REPRODUCTION, 2003, 18 (01) :100-107
[2]   Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta [J].
Aleksunes, Lauren M. ;
Cui, Yue ;
Klaassen, Curtis D. .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (09) :1960-1970
[3]   ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells [J].
Asashima, Tomoko ;
Hori, Satoko ;
Ohtsuki, Sumio ;
Tachikawa, Masanori ;
Watanabe, Masahiko ;
Mukai, Chisato ;
Kitagaki, Shinji ;
Miyakoshi, Naoki ;
Terasaki, Tetsuya .
PHARMACEUTICAL RESEARCH, 2006, 23 (06) :1235-1242
[4]   The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis [J].
Assaraf, Yehuda G. .
DRUG RESISTANCE UPDATES, 2006, 9 (4-5) :227-246
[5]   The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours [J].
Bart, J ;
Hollema, H ;
Groen, HJM ;
de Vries, EGE ;
Hendrikse, NH ;
Sleijfer, DT ;
Wegman, TD ;
Vaalburg, W ;
van der Graaf, WTA .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (14) :2064-2070
[6]   Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood-brain barrier [J].
Bihorel, Sebastien ;
Camenisch, Gian ;
Lemaire, Michel ;
Scherrmann, Jean-Michel .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (06) :1749-1757
[7]   Anticonvulsant hypersensitivity syndrome: Implications for pharmaceutical care [J].
Bohan, KarenBeth H. ;
Mansuri, Tarannum F. ;
Wilson, Natalie M. .
PHARMACOTHERAPY, 2007, 27 (10) :1425-1439
[8]   Retinal photodamage [J].
Boulton, M ;
Rózanowska, M ;
Rózanowski, B .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2001, 64 (2-3) :144-161
[9]   The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (gleevec): Implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients [J].
Breedveld, P ;
Pluim, D ;
Cipriani, G ;
Wielinga, P ;
van Tellingen, O ;
Schinkel, AH ;
Schellens, JHM .
CANCER RESEARCH, 2005, 65 (07) :2577-2582
[10]   The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models [J].
Breedveld, Pauline ;
Pluim, Dick ;
Cipriani, Greta ;
Dahlhaus, Femke ;
van Eijndhoven, Maria A. J. ;
de Wolf, Cornelia J. F. ;
Kuil, Annemieke ;
Beijnen, Jos H. ;
Scheffer, George L. ;
Jansen, Gerrit ;
Borst, Piet ;
Schellens, Jan H. M. .
MOLECULAR PHARMACOLOGY, 2007, 71 (01) :240-249